DR. CHRISTINE B WILSON M.D.
Prescription History 1669402921
Obstetrics & Gynecology in Hopwood, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. CHRISTINE B WILSON M.D., an active Obstetrics & Gynecology specialist practicing in Hopwood, PA. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 426 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 105 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Estradiol | 105 | $99.72▼ below PA avg | ▲ More than typical |
About Estradiol: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 105 Medicare prescriptions for Estradiol, about 3.3 times the volume of the typical Pennsylvania prescriber of this medication (32). Medicare paid an average of $99.72 per fill, versus $104.30 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 279.5 30-Day Fills standardized to 30-day supplies 8,259 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 63 | $9.71▼ below PA avg | ▲ More than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 63 Medicare prescriptions for Alendronate Sodium, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $9.71 per fill, versus $11.30 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 129.6 30-Day Fills standardized to 30-day supplies 3,837 Days of Medication total across all patients in 2023 | |||
| Oxybutynin Chloride ErOxybutynin Chloride | 60 | $34.64▼ below PA avg | ▲ More than typical |
About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾ It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida). In 2023, this provider wrote 60 Medicare prescriptions for Oxybutynin Chloride Er, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $34.64 per fill, versus $40.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 138 30-Day Fills standardized to 30-day supplies 4,140 Days of Medication total across all patients in 2023 | |||
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 59 | $31.02 | ▲ More than typical |
About Clotrimazole-Betamethasone: This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. Show more ▾ This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash. In 2023, this provider wrote 59 Medicare prescriptions for Clotrimazole-Betamethasone, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $31.02 per fill, versus $30.40 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 60.5 30-Day Fills standardized to 30-day supplies 1,576 Days of Medication total across all patients in 2023 | |||
| Fluconazole | 34 | $5.35▼ below PA avg | ▲ More than typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2023, this provider wrote 34 Medicare prescriptions for Fluconazole, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $5.35 per fill, versus $13.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 34 30-Day Fills standardized to 30-day supplies 313 Days of Medication total across all patients in 2023 | |||
| ProliaDenosumab | 29 | $1,652.18 | ≈ Typical |
About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. In 2023, this provider wrote 29 Medicare prescriptions for Prolia, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $1,652.18 per fill, versus $1,491.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 174 30-Day Fills standardized to 30-day supplies 5,220 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 24 | $541.96▼ below PA avg | ▼ Less than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 24 Medicare prescriptions for Myrbetriq, about half the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $541.96 per fill, versus $554.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| PremarinEstrogens, Conjugated | 21 | $436.08 | ≈ Typical |
About Premarin: This medication is a female hormone. Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. In 2023, this provider wrote 21 Medicare prescriptions for Premarin, about the same volume as the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $436.08 per fill, versus $402.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.2 30-Day Fills standardized to 30-day supplies 1,446 Days of Medication total across all patients in 2023 | |||
| Raloxifene Hcl | 17 | $71.20▼ below PA avg | ≈ Typical |
About Raloxifene Hcl: Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. Show more ▾ It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. In 2023, this provider wrote 17 Medicare prescriptions for Raloxifene Hcl, about 81% of the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $71.20 per fill, versus $85.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,530 Days of Medication total across all patients in 2023 | |||
| Ibandronate Sodium | 14 | $69.96 | ▼ Less than typical |
About Ibandronate Sodium: Ibandronate is used to prevent and treat certain types of bone loss (osteoporosis). Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause, as you age, or if you take corticosteroid medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Ibandronate belongs to a class of medications called bisphosphonates. Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS. In 2023, this provider wrote 14 Medicare prescriptions for Ibandronate Sodium, about half the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $69.96 per fill, versus $55.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.2 30-Day Fills standardized to 30-day supplies 1,206 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. CHRISTINE B WILSON M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Hopwood, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
